| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |